Diabetes & Endocrinology Time-Restricted Eating as a Promising Approach for Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence from a Randomized Controlled Trial MedXY Editorial Team Oct 28, 2025
Highlight
Time-restricted eating (TRE) significantly reduces hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) over 16 weeks.
TRE shows similar efficacy to traditional calorie restriction (CR) regarding weight loss, body composition, and metabolic parameters.
No serious adverse events were reported, suggesting TRE is a safe and practical dietary strategy for MASLD management.
Study Background MedXY registered readers
Sign in free to continue reading Create or use your MedXY account to unlock the complete article.
Sign in / Register This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Like 0 Dislike 0 Favorite 0 Share 0 
